	Predictors of active surveillance discontinuation in prostate cancer: Large Korean multicenter cohort study. Investig Clin Urol Choi J, Lee CU, Jeon SS, Byun SS, Joung JY, Ahn H, Cho JS, Park SW, Kwon DD, Ha US, Park JY, Kwon TG, Jo JK, Jeong CW, Kwak C, Prostate Cancer Study Group of the Korean Urological Oncology Society (KUOS). PMID: 42683858 [PubMed - in process]
	Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial. Investig Clin Urol Lee HW, Song G, Lee HH, Jung EH, Kim SY, Kim H, Park WS, Kwon J, Seo HK. PMID: 42683856 [PubMed - in process]
	Engineered human adipose-derived stem cells delivering carboxylesterase and TRAIL for castration-resistant prostate cancer: Translational synthesis. Investig Clin Urol Kim JH, Lee SH, Song YS. PMID: 42683853 [PubMed - in process]
	Impact of Systematic Biopsy Core Number on Clinically Significant Prostate Cancer Detection and Complications in MRI-Ultrasound Fusion Biopsy: A Retrospective Cohort Study. Cancer Manag Res Liu CY, Chang YH, Lin YH, Chen PH, Chang CB, Wang LJ, Wu CT, Pang ST, Lee WC, Fan LW, Li YR, Shao IH. PMID: 42683194 [PubMed]
	Comparative analysis of second and third-generation nanobody-based CAR-NK cells targeting PSMA in prostate cancer immunotherapy: In silico and in vitro studies. Iran J Basic Med Sci Gandomkar Ghalhar M, Karami Vandishi A, Ramazani A, Hajari Taheri F, Sharifzadeh Z, Abolhassani M, Soleimani M, Taghipour N, van Weerden WM, Bandehpour M, Hassani M, Bagherzadeh K. PMID: 42683068 [PubMed]
	Preoperative ADT combined with docetaxel for conversion therapy in large-volume and unresectable locally advanced or oligometastatic prostate cancer: a multicenter retrospective study (YHCG-001 study). Int J Surg Fei X, Huang RD, Xu YP, Wu W, Chen JC, Pan JF, Jia XL, Zheng Z, Zhou C, Su R, Zhao ZY, Ren DW, Wang SY, Zhao M, Liang LC, Li Y, Wang ZP, Jiang JH, Ma Q. PMID: 42682330 [PubMed]
	Empirical noise mapping guides optimal region-of-interest selection for accurate noise estimation in prostate DWI. J Appl Clin Med Phys Medved M, Chatterjee A, Yousuf A, Gundogdu B, Oto A, Karczmar GS. PMID: 42682154 [PubMed - indexed for MEDLINE]
	International Society of Urological Pathology Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Effects in Prostate and Bladder Cancer: Working Group 2: The Urinary Bladder. Am J Surg Pathol Downes MR, Wobker SE, Smith SC, Eckstein M, Akgul M, Baydar DE, Brimo F, Compérat E, Hartmann A, Kamat AM, Lobo A, Raspollini MR, Sangoi AR, Shariat SF, Tsuzuki T, van Rhijn BWG, Williamson SR, van Leenders GJLH, Cheng L, Lopez-Beltran A, Members of ISUP GU Cancer Treatment Effects Consensus Panel. PMID: 42682094 [PubMed - as supplied by publisher]
	Primary malignant melanoma of the female urethra: a case report and literature review. Can J Urol Xie J, Zhang Q, Wu J, Ma Y, Yan Y, Huang X. PMID: 42682069 [PubMed - indexed for MEDLINE]
	Renal Ewing sarcoma with an unusual presentation: a case report. Can J Urol Lübbersmeyer F, Lindfeld P, Fisch M, Dahlem R, Von Deimling M. PMID: 42682068 [PubMed - indexed for MEDLINE]
	At a glans: metastatic prostate cancer disguised as penile squamous cell carcinoma; a case report. Can J Urol Narasimhan R, Sugiyama K, Wang J, Munarriz R, Sarita-Reyes C. PMID: 42682067 [PubMed - indexed for MEDLINE]
	Unintended consequences of antibiotic practices: the relationship between bowel preparation, prolonged prophylaxis, and ileus after radical cystectomy. Can J Urol Manivasagam SS, Clark JY, Raman JD. PMID: 42682052 [PubMed - indexed for MEDLINE]
	Impact of leuprolide and goserelin on androgen suppression and adverse events in patients with prostate cancer. Can J Urol Freitas CSM, Rocha-Silva F, Marques-Silva TA, de Oliveira ACR, da Silva SG, Santos Cardoso FD, Soares AN. PMID: 42682049 [PubMed - indexed for MEDLINE]
	Pathologic failure and salvage approaches following focal therapy for localized prostate cancer. Can J Urol Tremblay S, Tabei SS, Tayebi S, Hinrichs BH, Lazarovich A, Koehler J, Hsu WW, Verma S, Sidana A. PMID: 42682046 [PubMed - indexed for MEDLINE]
	Artificial intelligence advances in cystoscopy and imaging for bladder cancer: a narrative review. Can J Urol Khalid U, Shah N, Kavia R, Batura D. PMID: 42682041 [PubMed - indexed for MEDLINE]
	Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [(225)Ac]Ac-/[(177)Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study. BMC Cancer Amghar M, Hielscher T, Rausch T, Özgür H, Bauder-Wüst U, Rathke H, Bruchertseifer F, Morgenstern A, Roscher M, Bene, Kratochwil C, Bene. PMID: 42681619 [PubMed - indexed for MEDLINE]
	Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin. Cancer Med Odagiri K, Morikawa T, Naiki T, Sugiyama Y, Tasaki Y, Mimura Y, Naiki-Ito A, Nagai T, Etani T, Iida K, Ishikawa D, Noda Y, Shimizu N, Aoki M, Gonda M, Banno R, Kubota H, Ando R, Umemoto Y, Kawai N, Furukawa-Hibi Y, Yasui T. PMID: 42681561 [PubMed - indexed for MEDLINE]
	Delphi consensus of specialist radiologists on imaging criteria for gadolinium contrast use and whole-body MRI in prostate cancer. Insights Imaging Onwuharine EN, Clark AJ, Dimmock M, Hill J. PMID: 42681263 [PubMed]
	Renal cell carcinoma: molecular understanding and therapeutic development. Cell Death Differ Hou T, Hua X, Ni W, Yan P, Inuzuka H, Wei W. PMID: 42680845 [PubMed - as supplied by publisher]
	Editorial for "Accuracy of Quantitative Chemical-Exchange-Saturation-Transfer Imaging for Grading Prostate Cancer and Predicting Adverse Pathology". J Magn Reson Imaging Zu Z. PMID: 42680717 [PubMed - as supplied by publisher]

Articles 1 - 20 / 181179

Page 1 of 9059



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy